# Transfusion of Biotinylated Red Blood Cells

> **NCT02757898** · PHASE1 · COMPLETED · sponsor: **Emory University** · enrollment: 5 (actual)

## Conditions studied

- Anemia

## Interventions

- **DRUG:** Biotin-Labeled Red Blood Cells (RBCs)

## Key facts

- **NCT ID:** NCT02757898
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-11
- **Primary completion:** 2018-11-13
- **Final completion:** 2018-11-13
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2023-05-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02757898

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02757898, "Transfusion of Biotinylated Red Blood Cells". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02757898. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*